Histo-Blood Group Antigens in Children with Symptomatic Rotavirus Infection
- PMID: 30974776
- PMCID: PMC6520971
- DOI: 10.3390/v11040339
Histo-Blood Group Antigens in Children with Symptomatic Rotavirus Infection
Abstract
Group A rotaviruses are a major cause of acute gastroenteritis in children. The diversity and unequal geographical prevalence of rotavirus genotypes have been linked to histo-blood group antigens (HBGAs) in different human populations. In order to evaluate the role of HBGAs in rotavirus infections in our population, secretor status (FUT2+), ABO blood group, and Lewis antigens were determined in children attended for rotavirus gastroenteritis in Valencia, Spain. During three consecutive years (2013-2015), stool and saliva samples were collected from 133 children with rotavirus infection. Infecting viral genotypes and HBGAs were determined in patients and compared to a control group and data from blood donors. Rotavirus G9P[8] was the most prevalent strain (49.6%), followed by G1P[8] (20.3%) and G12P[8] (14.3%). Rotavirus infected predominantly secretor (99%) and Lewis b positive (91.7%) children. Children with blood group A and AB were significantly more prone to rotavirus gastroenteritis than those with blood group O. Our results confirm that a HBGA genetic background is linked to rotavirus P[8] susceptibility. Rotavirus P[8] symptomatic infection is manifestly more frequent in secretor-positive (FUT2+) than in non-secretor individuals, although no differences between rotavirus G genotypes were found.
Keywords: ABO group antigens; Lewis; gastroenteritis; histo-blood group antigens (HBGAs); rotavirus; secretor; susceptibility.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Tate J.E., Burton A.H., Boschi-Pinto C., Steele A.D., Duque J., Parashar U.D. WHO-coordinated Global Rotavirus Surveillance Network. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: A systematic review and meta-analysis. Lancet Infect. Dis. 2012;12:136–141. doi: 10.1016/S1473-3099(11)70253-5. - DOI - PubMed
-
- Armah G.E., Sow S.O., Breiman R.F., Dallas M.J., Tapia M.D., Feikin D.R., Binka F.N., Steele A.D., Laserson K.F., Anasah N.A., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:606–614. - PubMed
-
- Madhi S.A., Cunliffe N.A., Steele D., Witte D., Kirsten M., Louw C., Ngwira B., Victor J.C., Gillard P.H., Cheuvart B.B., et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N. Engl. J. Med. 2010;362:289–298. - PubMed
-
- Harris V.C., Armah G., Fuentes S., Korpela K.E., Parashar U., Victor J.C., Tate J., de Weerth C., Giaquinto C., Wiersinga W.J., et al. Significant correlation between the infant gut microbiome and rotavirus vaccine response in rural Ghana. J. Infect. Dis. 2017;215:34–41. doi: 10.1093/infdis/jiw518. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
